248
Participants
Start Date
May 31, 2014
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Mitiglinide
three times a day, orally, for 12 weeks
Acarbose
three times a day, orally, for 12 weeks
The First People's Hospital of Changzhou, Changzhou
The Second People's Hospital of Huai'an, Huai'an
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University, Nanjing
Xuzhou Central Hospital, Xuzhou
Yancheng City No.1 People's Hospital, Yancheng
Zhenjiang First People's Hospital, Zhenjiang
Zhongda Hospital
OTHER